Search

everythinglearnresearchcommunity

for

Search:↓

CAR is a useful marker for assessing alopecia areata severity.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Male baldness is not significantly associated with coronary artery disease.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Finasteride helps reduce heart enlargement in heart failure patients.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Electron Beam Tomography (EBT) is a useful additional test to stress testing for detecting heart disease.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.